Two biotinylated derivatives of the main hop chalcone xanthohumol (1) were 12 prepared by a one-step synthesis via esterification using biotin and 1-ethyl-3-(3- 
suplement, which especially during pregnancy is important for normal fetal development. Recent studies revealed that xanthohumol has also the ability to sensitize MCF-7/ADR cells 56 to doxorubicin, which increases cytotoxic effect of this chemotherapy drug [7] . The most 57 often described mechanism of anticancer activity of xanthohumol involves its ability to 58 suppress cell proliferation and induce programmed cell death in cancerous cells [8] [9] .
59
Xanthohumol and its structural analogues are also inhibitors of many enzymes, such as 60 cyclooxygenase and lipoxygenase, which can lead to formation of reactive oxygen species.
61
The multiple functionalities make these polyphenols distinguished chelators, through their 62 hydroxyl groups, to the metallic part of the enzymes and thus, act as competitive inhibitors 
Results and Discussion

84
Chemical covalent modification of flavonoids is a way to improve the hydrophobic 85 nature of these compounds. We decided to synthesize biotin derivatives of XN (1) so as to Xanhtohumol (1), the main prenylated hop chalcone, may inhibit cell growth and induce 144 apoptosis in many types of human cancers, including breast cancer [6] .
145
To better understand the influence of flavonoid compounds on the aggressive kind of triple- used as a non-cancerous control.
153
In this study we found that both biotinylated xanthohumols (2 and 3) demonstrated 
166
The effect of 1 on MCF-7 breast cancer cells was described earlier by Yoshimaru et al.
167
[26], with IC50 value = 8.7 µM, which is in accordance with our observations. The authors 
189
The last molecular studies using BALB/c-4T1 breast cancer mouse model showed that MA, USA).
247
The purity of synthesized products was monitored by HPLC using an Ultimate 3000 
Chemistry
261
EDC (230 mg, 1.2 mmol) and DMAP (74 mg, 0.6 mmol) were added to a mixture of 262 xanthohumol (1) (100 mg, 0.28 mmol) and biotin (276 mg, 1.13 mmol) in DMF (10 ml).
263
The reaction mixture was stirred at 58 °C for 24 h. The crude products were directly purified 264 by flash chromatography and characterised using spectroscopic methods. Poland), and streptomycin (100 μg/mL; Sigma-Aldrich, Germany). All cell lines were grown 310 at 37°C in a 5% CO2 humidified atmosphere.
311
Prior to usage, the compounds were dissolved in DMSO to achieve the concentration of 312 50 mM, and subsequently diluted in culture medium to reach the required concentrations
313
(ranging from 0.4 μM to 250 μM).
314
24 Hours before addition of tested compounds, the cells were placed in 96-well plates 
319
The test was carried out according to the method described before [32] .
320
The results were calculated as an IC50 (inhibitory concentration 50) -the concentration 321 of tested agent that inhibits proliferation of the cell population by 50%. IC50 values were 322 calculated for each experiment separately and mean values ± SD are presented in Table 1 .
323
Each compound in each concentration was tested in triplicate in a single experiment, which 324 was repeated 3-5 times. 
Conclusion
342
Here, we present a new approach to identify biotinylated analogues of prenylated hops). This waste material is rich in 1, which we used as a substrate for the synthesis of 2 and 362 its derivatives.
363
These studies are in progress. The aim of further work is also to elucidate the mechanism 364 of the cytotoxicity of biotin-modified flavonoids. 
